From Black and White to Shades of Gray. Race and Renin-Angiotensin System Blockade**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 19, 2008, Pages 1872-1873

  Havranek, Edward P ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; LISINOPRIL; PERINDOPRIL; TELMISARTAN; VALSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; EDITORIAL; GENETIC PREDISPOSITION; HEART EJECTION FRACTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPERTENSION; KIDNEY DYSFUNCTION; MONOTHERAPY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RACE DIFFERENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

AFRICAN AMERICANS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CAPTOPRIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; UNITED STATES; VALINE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 42949162148     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.01.039     Document Type: Editorial

References (7)

1. Prisant L.M., Thomas K.L., Lewis E.F., et al. Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol 51 (2008) 1865-1871
2. Exner D.V., Dries D.L., Domanski M.J., and Cohn J.N. Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction. N Engl J Med 344 (2001) 1351-1357
3. Wright J.T., Dunn J.K., Cutler J.A., et al. Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA 293 (2005) 1595-1608
4. Cohn J.N., Julius S., Neutel J., et al. Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial. Am J Hypertens 17 (2004) 134-138
5. Smith M.W., Patterson N., Lautenberger J.A., et al. A high-density admixture map for disease gene discovery in African Americans. Am J Hum Genet 74 (2004) 1001-1013
6. Hawks J., Wang E., Cochran G.M., Harpending H.C., and Moyzis R.K. Recent acceleration of human adaptive evolution. Proc Nat Acad Sci 104 (2007) 20753-20758
7. Bakris G.L., Smith D.H., Giles T.D., White W.B., Davidai G., and Weber M.A. Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients. J Clin Hypertens (Greenwich) 7 (2005) 587-595